FR3061013B1 - Composition contenant le digeneaside, son procede d'obtention et son utilisation cosmetique, veterinaire ou nutraceutique - Google Patents

Composition contenant le digeneaside, son procede d'obtention et son utilisation cosmetique, veterinaire ou nutraceutique Download PDF

Info

Publication number
FR3061013B1
FR3061013B1 FR1601847A FR1601847A FR3061013B1 FR 3061013 B1 FR3061013 B1 FR 3061013B1 FR 1601847 A FR1601847 A FR 1601847A FR 1601847 A FR1601847 A FR 1601847A FR 3061013 B1 FR3061013 B1 FR 3061013B1
Authority
FR
France
Prior art keywords
digeneaside
veterinary
cosmetic
composition containing
obtaining same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1601847A
Other languages
English (en)
Other versions
FR3061013A1 (fr
Inventor
Philippe Bernard
Franck HIMBERT
Quoc Tuan DO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Greenpharma SAS
Original Assignee
Greenpharma SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greenpharma SAS filed Critical Greenpharma SAS
Priority to FR1601847A priority Critical patent/FR3061013B1/fr
Publication of FR3061013A1 publication Critical patent/FR3061013A1/fr
Application granted granted Critical
Publication of FR3061013B1 publication Critical patent/FR3061013B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C07H1/08—Separation; Purification from natural products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne l'obtention du digénéaside, sa préparation et son utilisation dans des compositions cosmétiques, vétérinaires ou nutraceutiques destinées à prévenir ou traiter les troubles liés au vieillissement naturel ou prématuré de la peau et des phanères, par voie orale et/ou topique.
FR1601847A 2016-12-22 2016-12-22 Composition contenant le digeneaside, son procede d'obtention et son utilisation cosmetique, veterinaire ou nutraceutique Expired - Fee Related FR3061013B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1601847A FR3061013B1 (fr) 2016-12-22 2016-12-22 Composition contenant le digeneaside, son procede d'obtention et son utilisation cosmetique, veterinaire ou nutraceutique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1601847 2016-12-22
FR1601847A FR3061013B1 (fr) 2016-12-22 2016-12-22 Composition contenant le digeneaside, son procede d'obtention et son utilisation cosmetique, veterinaire ou nutraceutique

Publications (2)

Publication Number Publication Date
FR3061013A1 FR3061013A1 (fr) 2018-06-29
FR3061013B1 true FR3061013B1 (fr) 2020-04-17

Family

ID=58645105

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1601847A Expired - Fee Related FR3061013B1 (fr) 2016-12-22 2016-12-22 Composition contenant le digeneaside, son procede d'obtention et son utilisation cosmetique, veterinaire ou nutraceutique

Country Status (1)

Country Link
FR (1) FR3061013B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3088195B1 (fr) * 2018-11-12 2021-05-28 Amadeite Extrait d'algues rouges pour son utilisation pour la prevention ou le traitement d'un trouble intestinal
CN116747158B (zh) * 2023-08-01 2024-01-23 广州市花木草生物科技有限公司 一种通过线粒体抗皱紧致的化妆品组合物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10040933A1 (de) * 2000-08-18 2002-03-07 Bitop Gmbh Verwendung von beta-Mannosylglycerat (Firoin) und/oder Derivaten, insbesondere dem beta-Mannosylglyceramid (Firoin-A), in kosmetischen und dermatologischen Formulierungen
FR3013219B1 (fr) * 2013-11-18 2016-06-10 Agrimer Procede d'obtention d'extraits d'algues marines
RU2731563C2 (ru) * 2014-03-14 2020-09-04 Факулдади Ди Сиенсиас Да Универсидади Ди Лисбоа Производные гексозы, их получение и применение
JP2016003212A (ja) * 2014-06-17 2016-01-12 国立研究開発法人産業技術総合研究所 コラーゲン産生促進剤
FR3022458A1 (fr) * 2014-06-23 2015-12-25 Univ Bretagne Occidentale Utilisation du mannosylglycerate et ses derives comme agent immunostimulant

Also Published As

Publication number Publication date
FR3061013A1 (fr) 2018-06-29

Similar Documents

Publication Publication Date Title
MA40111A1 (fr) Dérivés du tétrahydronaphtalène inhibant la protéine mcl-1
MD3433234T2 (ro) Modulatori alosterici ai receptorilor nicotinici de acetilcolină
FR3028753B1 (fr) Gel aqueux ou hydroalcoolique de phyllosilicates synthetiques a titre d'agent viscosant, matifiant et/ou homogeneisant d'application
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
CY1110965T1 (el) Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου
ATE411280T1 (de) Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege
ATE432278T1 (de) Verbindungen zur behandlung von krankheiten
MA49628B1 (fr) Processus pour la purification de l'acide hyaluronique
MA47356B1 (fr) Dérivés d'isochromène utiles en tant qu'inhibiteurs des phosphoinositide 3-kinases
ATE457027T1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht
FR2939135B1 (fr) Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
MA34545B1 (fr) Co-cristaux et sels d'inhibiteurs de ccr3
CY1116234T1 (el) Υποκατεστημενα 2-οξυ-κινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
EA201891612A1 (ru) Производные 3-(карбоксиметил)-8-амино-2-оксо-1,3-диазаспиро[4.5]декана
DE60326069D1 (de) 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen
FR3061013B1 (fr) Composition contenant le digeneaside, son procede d'obtention et son utilisation cosmetique, veterinaire ou nutraceutique
EA201891611A1 (ru) Роизводные 3-((гетеро-)арил)-8-амино-2-оксо-1,3-диазаспиро[4,5]декана
EP4272832A3 (fr) Composés antimicrobiens, compositions et leurs utilisations
FR2885491B1 (fr) Traitement de la secheresse keratinique par des glycerides
MA39253B1 (fr) Composés hétéroaryle bicycliques substitués utilisés comme agonistes de rxr
MA44965B1 (fr) Dérivés de pyridinyle, compositions pharmaceutiques et utilisations de ceux-ci en tant qu'inhibiteurs d'aoc3
CY1116158T1 (el) Υποκατεστημενα 2-οξο- και 2-θειοξο-διυδροκινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
ATE524463T1 (de) 4-chromenonyl-1,4-dihydropyridincarbonitrile und ihre verwendung
EP2020223A3 (fr) Produit de soin capillaire ayant une teneur en diamants
DE602005027228D1 (de) Zusammensetzungen und verfahren zur behandlung von krankheiten, die durch infektion mit yersinia spp ausgelöst sind

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20180629

PLFP Fee payment

Year of fee payment: 4

ST Notification of lapse

Effective date: 20190906

RN Application for restoration

Effective date: 20191014

FC Decision of inpi director general to approve request for restoration

Effective date: 20191202

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8